Risk Factors of Lymph Edema in Breast Cancer Patients

Author:

Shahpar Haghighat1,Atieh Akbari2,Maryam Ansari1,Fatemeh Homaei Shandiz3,Massoome Najafi4,Mandana Ebrahimi1,Masud Yunesian5,Hamid Reza Mirzaei2,Mohammad Esmaeil Akbari26

Affiliation:

1. Breast Cancer Research Group, Breast Cancer Research Center (BCRC), ACECR, Tehran 1315685981, Iran

2. Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences, Tehran 1989934148, Iran

3. Solid Tumor Treatment Research Center, Mashhad University of Medical University, Mashhad 91397, Iran

4. Cancer Institute, Tehran University of Medical Sciences, Tehran 1419733141, Iran

5. Tehran University of Medical Sciences, Tehran 1411717415, Iran

6. Cancer Research Center, Shohada Hospital, Tajrish Square, Tehran, Iran

Abstract

Background. Lymphedema secondary to breast cancer treatment is a common and serious problem for disease survivors. The objective of the current study was to identify the risk factors of secondary lymphedema after breast carcinoma treatment.Materials & Methods. The breast cancer patients who were followed up in three centers in Tehran and Mashhad in 2010 were recruited in the study. The circumference measurement was used for defining lymphedema.Results. Among 410 breast cancer patients, 123 cases (30%) developed lymphedema. Variables such as low educational level, body mass index (BMI), higher stage of disease, number of involved lymph nodes, comorbid diseases, trauma, infection, and the time after surgery showed significant correlation with the development of lymphedema. In logistic regression analysis, increase of 1 kg/m2in BMI (OR = 1.09; 95%  CI 1.05–1.15), each number increase in lymph node involvement (OR = 1.15; 95%  CI 1.08–1.21) and the increase of every 1 month after surgery (OR = 1.01; 95%  CI 1.01–1.02) significantly increased the risk of lymphedema.Conclusion. The results of this study demonstrated that preserving a fitted BMI, emphasis on self-care, and educating preventive activities may have important roles in decreasing the lymphedema incidence and improving the patients’ quality of life.

Funder

Academic Center for Education, Culture and Research

Publisher

Hindawi Limited

Subject

Cancer Research,Pharmacology (medical),Oncology

Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3